236 related articles for article (PubMed ID: 27527355)
21. Effect of neointimal tissue morphology on vascular response to balloon angioplasty in lesions with in-stent restenosis after drug-eluting stent deployment: an optical coherence tomography analysis.
Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Shimatani Y; Hasegawa K; Ishibuchi K; Tamaru H; Ishii R; Yasuda S; Taniguchi Y; Nakabayashi S; Kusumoto H; Higashino Y
Heart Vessels; 2020 Sep; 35(9):1193-1200. PubMed ID: 32253529
[TBL] [Abstract][Full Text] [Related]
22. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
[TBL] [Abstract][Full Text] [Related]
23. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography.
Ellert J; Antonsen L; Jensen LO
Cardiovasc Revasc Med; 2017; 18(3):207-211. PubMed ID: 27650886
[TBL] [Abstract][Full Text] [Related]
24. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
[No Abstract] [Full Text] [Related]
26. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
27. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
28. Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial.
Burzotta F; Brancati MF; Trani C; Pirozzolo G; De Maria G; Leone AM; Niccoli G; Porto I; Prati F; Crea F
Heart Vessels; 2016 May; 31(5):677-86. PubMed ID: 25863804
[TBL] [Abstract][Full Text] [Related]
29. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
[TBL] [Abstract][Full Text] [Related]
30. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
[TBL] [Abstract][Full Text] [Related]
31. Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
Nakajima Y; Itoh T; Morino Y
Catheter Cardiovasc Interv; 2016 Mar; 87(4):E137-42. PubMed ID: 26011018
[TBL] [Abstract][Full Text] [Related]
32. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
34. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
[TBL] [Abstract][Full Text] [Related]
35. Recurrent In-Stent Restenosis With Eccentric Neointimal Hyperplasia at a Lesion With Hingelike Motion.
Ishida K; Minami Y; Fujiyoshi K; Ishida M; Ako J; Inomata T
JACC Cardiovasc Interv; 2020 Jun; 13(11):e103-e104. PubMed ID: 32222444
[No Abstract] [Full Text] [Related]
36. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
37. Optimal visualization of five different stent layers during and after percutaneous coronary intervention for recurrent in-stent restenosis using optical coherence tomography (OCT).
Movahed MR; Ram V; Arsanjani R
Cardiovasc Revasc Med; 2012; 13(5):292-4. PubMed ID: 22727600
[TBL] [Abstract][Full Text] [Related]
38. Successful double-layer metal stents rotational ablation under 2-dimensional and 3-dimensional optical coherence tomography guidance: a case report.
Yaliang T; Guohui L; Cheng Z; Beibei D; Yanan Z; Yuquan H; Ping Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):173. PubMed ID: 33849433
[TBL] [Abstract][Full Text] [Related]
39. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
